Back to all papers

Ultrasound and SWE-based transfer learning for predicting fibrotic NASH.

December 29, 2025pubmed logopapers

Authors

Xia F,Wang K,Wang Y,Zhang C,Wang J

Affiliations (5)

  • Department of Ultrasound, The Second People's Hospital, WuHu Hospital, East China Normal University, WuHu), No.259 Jiuhuashan Road, Jinghu District, Wuhu, 241001, Anhui, China.
  • School of Graduate Studies, Bengbu Medical College, No. 2600 Donghai Avenue, Longzihu District, Bengbu, 233030, Anhui Province, China.
  • Department of Ultrasound, The First Affiliated Hospital of Anhui Medical University, No.21 Jixi Road, Shushan District, Hefei, 230022, Anhui, China.
  • Department of Ultrasound, The Second People's Hospital, WuHu Hospital, East China Normal University, WuHu), No.259 Jiuhuashan Road, Jinghu District, Wuhu, 241001, Anhui, China. [email protected].
  • School of Graduate Studies, Bengbu Medical College, No. 2600 Donghai Avenue, Longzihu District, Bengbu, 233030, Anhui Province, China. [email protected].

Abstract

The aim of this study was to develop a combined deep-learning model utilizing liver ultrasound, liver elastography images, and clinical features to predict and diagnose fibrotic non-alcoholic steatohepatitis (NASH). A rat model of liver steatosis and fibrosis was established through a high-fat diet and subcutaneous CCl₄ injections. Two-dimensional ultrasound and shear wave elastography (SWE) images were acquired. Three deep learning models, based on the ResNet-18 architecture, were designed: (1) a pure image model using only liver ultrasound, (2) a pure image model using only liver elastography, and (3) a combined model incorporating liver ultrasound, liver elastography images, and clinical features. The performance of these models was evaluated using three-fold cross-validation, receiver operating characteristic (ROC) curves, decision curve analysis (DCA), and calibration curves. The combined deep learning model demonstrated the highest area under the curve (AUC) of 0.879. DCA revealed that the multimodal model provided superior net benefits across most threshold probability ranges for predicting and diagnosing fibrotic NASH. The combined deep learning model based on the ResNet-18 architecture exhibits promising performance in predicting and diagnosing fibrotic NASH.

Topics

Non-alcoholic Fatty Liver DiseaseElasticity Imaging TechniquesLiver CirrhosisDeep LearningJournal Article

Ready to Sharpen Your Edge?

Subscribe to join 7,800+ peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.